LINGYIMED
Latest round
- Series A
Last raised
- May 2023
Total raised
- $14M
Investors
- 5
About LINGYIMED
, trading as LINGYIMED, is a biotechnology company that focuses on the metabolic, CNS, ophthalmology, and other disease fields, that was established by Dr. Qing Lin and Dr. Yixiong Chen, who are from WuXi AppTec that is a new drug research and development company. Also, Lingyi Biotechnology has been successful in 30 rare disease projects., Ltd. The company focuses on the gene therapy field. It has developed a technology platform, including a rare disease model, Aav carrier development, and a production process platform. Specific product lines include Inherited Metabolic Disorders (IMDS), neurodegenerative diseases, and inherited retinal diseases (IRDS). The company’s revenue is generated by providing rare disease animal model functional validation platform and gene therapy.
Who invested in LINGYIMED
5 investors across 1 round
See all investors in LINGYIMED
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
May 6, 2023
Amount
$14M
Investors
Questions about LINGYIMED
Who invested in LINGYIMED?
LINGYIMED has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has LINGYIMED raised?
LINGYIMED has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did LINGYIMED last raise money?
LINGYIMED's most recent round on record is a Series A, in May 2023.
What does LINGYIMED do?
, trading as LINGYIMED, is a biotechnology company that focuses on the metabolic, CNS, ophthalmology, and other disease fields, that was established by Dr.
Where is LINGYIMED headquartered?
LINGYIMED is headquartered in Shanghai, China.
Which VCs invest in companies like LINGYIMED?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at LINGYIMED's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like LINGYIMED? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.